Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AramarkARMK · Entity 3359 | Director | September 09, 2026 | September 10, 2026 |
| DEXCOM INCDXCM · Entity 3114 | Director | August 12, 2026 | August 13, 2026 |
| Merck & Co., Inc.MRK · Entity 2807 | Exe.VP & Pres.Con.Hlth.Care | May 09, 2014 | May 13, 2014 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aramark
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,896.827 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Grant · Acquired 75.532 · Balance 35,896.827 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards.
DEXCOM INC
Report date August 12, 2026 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,570 |
Reported balance
After 2026-08-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-12 · Sale · Disposed 1,012 · Balance 29,570 F1: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2: Included in this number are 5,575 unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: Included in this number are 5,575 unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders.
Merck & Co., Inc.
Report date May 09, 2014 · Filed May 13, 2014
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $58.22 · Expires 2024-05-08 | Direct | 60,523 |
Reported balance
After 2014-05-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2014-05-09 · Grant · Acquired 60,523 · Balance 60,523 F2: The option vests in three equal annual installments beginning May 9, 2015. |
| Common StockSEC Table I · non-derivative | Direct | 35,473.7 |
Reported balance
Holding disclosure · report date 2014-05-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 35,473.7 F1: Holdings include shares acquired in dividend reinvestment transactions. |
Filing footnotes · ownership attribution and instrument terms
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: The option vests in three equal annual installments beginning May 9, 2015.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTEGRAL AD SCIENCE HOLDING CORP.
Report date December 23, 2025 · Filed December 23, 2025
Section 16 reporting ended · disclosed 2025-12-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-12-23 transaction · row 1
1 source rowRow 1 · 2025-12-23 · Disposition to issuer · Disposed 62,661 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of September 24, 2025 (the "Merger Agreement"), by and among the Issuer, Igloo Group Parent, Inc. ("Parent") and Igloo Group Acquisition Company, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), owned by the reporting person immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $10.30 per share in cash, without interest thereon (the "Per Share Price"). F2: The shares of Common Stock reported as disposed by the reporting person include 17,637 unvested restricted stock units ("Company RSUs") which were, at or immediately prior the Effective Time, fully vested, cancelled and converted into the right to receive, without interest, an amount in cash equal to the product of (i) the Per Share Price and (ii) the total number of shares of Common Stock subject to such Company RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of September 24, 2025 (the "Merger Agreement"), by and among the Issuer, Igloo Group Parent, Inc. ("Parent") and Igloo Group Acquisition Company, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), owned by the reporting person immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $10.30 per share in cash, without interest thereon (the "Per Share Price").
F2: The shares of Common Stock reported as disposed by the reporting person include 17,637 unvested restricted stock units ("Company RSUs") which were, at or immediately prior the Effective Time, fully vested, cancelled and converted into the right to receive, without interest, an amount in cash equal to the product of (i) the Per Share Price and (ii) the total number of shares of Common Stock subject to such Company RSUs.
TECH DATA CORP
Report date June 30, 2020 · Filed July 02, 2020
Section 16 reporting ended · disclosed 2020-07-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-06-30 transaction · row 1
1 source rowRow 1 · 2020-06-30 · Disposition to issuer · Disposed 6,933 · Balance 0 F1: Tech Data Corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 12, 2019 and amended on November 27, 2019 (the "Merger Agreement"), by and among the Company, Tiger Midco, LLC, a Delaware limited liability company ("Parent") and Tiger Merger Sub Co., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"). On June 30, 2020, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, each share of Company common stock and each restricted stock unit subject to time-based vesting that was outstanding as of the closing of the merger was converted into the right to receive an amount in cash equal to $145.00, without interest and net of any required withholding of taxes. F2: Represents shares of Common Stock held by the Reporting Person. In connection with the closing of the transactions contemplated by the Merger Agreement, each share of Common Stock held by the Reporting Person as of the closing of the merger was converted into the right of the Reporting Person to receive a cash payment of $145.00, without interest and net of any required withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Tech Data Corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 12, 2019 and amended on November 27, 2019 (the "Merger Agreement"), by and among the Company, Tiger Midco, LLC, a Delaware limited liability company ("Parent") and Tiger Merger Sub Co., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"). On June 30, 2020, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Parent. Pursuant to the terms of the Merger Agreement, each share of Company common stock and each restricted stock unit subject to time-based vesting that was outstanding as of the closing of the merger was converted into the right to receive an amount in cash equal to $145.00, without interest and net of any required withholding of taxes.
F2: Represents shares of Common Stock held by the Reporting Person. In connection with the closing of the transactions contemplated by the Merger Agreement, each share of Common Stock held by the Reporting Person as of the closing of the merger was converted into the right of the Reporting Person to receive a cash payment of $145.00, without interest and net of any required withholding of taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:16 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 75.532 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-26-000135 · wk-form4_1789071388.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,896.827 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 12, 2026 Filed Aug 13, 2026 20:04 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,012 | $88.29 | $89,349.48 |
DisclosureSEC source: 0001485616-26-000006 · wk-form4_1786651440.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,570 F1 · shares: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 5,575 unvested restricted stock units which were granted on May 28, 2026 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:25 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 80.107 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-26-000098 · wk-form4_1780611938.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,821.295 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 28, 2026 Filed Jun 1, 2026 21:34 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-26-000121 · wk-form4_1780349687.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,582 F1 · shares: The RSU Award was granted on May 28, 2026 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2027 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 12, 2026 Filed May 14, 2026 20:39 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,012 | $60.01 | $60,730.12 |
DisclosureSEC source: 0001485616-26-000004 · wk-form4_1778791153.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,007 F1 · shares: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:39 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 104.1 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-26-000071 · wk-form4_1772746782.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,741.188 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:36 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,012 | $68.01 | $68,826.12 |
DisclosureSEC source: 0001485616-26-000002 · wk-form4_1771364201.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,019 F1 · shares: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Read SEC document |
| February 03, 2026 Filed Feb 4, 2026 21:33 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 5,124 | $38.06 | $195,019.44 |
DisclosureSEC source: 0001584509-26-000022 · wk-form4_1770240795.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,637.088 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 23, 2025 Filed Dec 23, 2025 20:11 UTC | INTEGRAL AD SCIENCE HOLDING CORP. IAS · Entity 70858 | Disposition to issuerCommon Stock, $0.001 par value | 62,661 | $10.30 | $645,408.30 |
DisclosureSEC source: 0001193125-25-331266 · ownership.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of September 24, 2025 (the "Merger Agreement"), by and among the Issuer, Igloo Group Parent, Inc. ("Parent") and Igloo Group Acquisition Company, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), owned by the reporting person immediately prior to the Effective Time was automatically cancelled, extinguished and converted into the right to receive $10.30 per share in cash, without interest thereon (the "Per Share Price"). F2 · kind: The shares of Common Stock reported as disposed by the reporting person include 17,637 unvested restricted stock units ("Company RSUs") which were, at or immediately prior the Effective Time, fully vested, cancelled and converted into the right to receive, without interest, an amount in cash equal to the product of (i) the Per Share Price and (ii) the total number of shares of Common Stock subject to such Company RSUs. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:16 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 96.688 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000242 · wk-form4_1766096192.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,513.088 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 12, 2025 Filed Nov 12, 2025 22:14 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,012 | $58.07 | $58,766.84 |
DisclosureSEC source: 0001093557-25-000286 · wk-form4_1762985674.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,031 F1 · shares: On August 14, 2025, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 5,046 unvested restricted stock units which were granted on May 8, 2025 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 20:24 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 79.515 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000187 · wk-form4_1755807879.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,416.4 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 28, 2025 Filed May 29, 2025 20:37 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 79.228 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000143 · wk-form4_1748551014.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,336.885 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 09, 2025 Filed May 13, 2025 16:06 UTC | INTEGRAL AD SCIENCE HOLDING CORP. IAS · Entity 70858 | GrantCommon Stock, $0.001 par value | 17,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001842718-25-000064 · wk-form4_1747166783.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,661 F1 · kind: Represents Restricted Stock Units which will be settled in shares of common stock of the Issuer and will vest in full on the anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 08, 2025 Filed May 12, 2025 20:08 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 5,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-25-000151 · wk-form4_1747080500.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,043 F1 · shares: The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 21:02 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 352 | $70.33 | $24,756.16 |
DisclosureSEC source: 0001093557-25-000083 · wk-form4_1742418120.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,997 F1 · shares: On February 25, 2024, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,618 unvested restricted stock units which were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2025 Annual Meeting of Stockholders. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 21:09 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 85.233 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000076 · wk-form4_1740517770.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,257.657 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 22:45 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-25-000033 · wk-form4_1738017932.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,172.424 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 21:15 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,000 | $76.87 | $76,870.00 |
DisclosureSEC source: 0001093557-24-000189 · wk-form4_1734470113.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,349 F1 · shares: On February 25, 2024, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,618 unvested restricted stock units which were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2025 Annual Meeting of Stockholders. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:06 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 65.253 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000292 · wk-form4_1734123960.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,172.424 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:17 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,000 | $70.00 | $70,000.00 |
DisclosureSEC source: 0001093557-24-000172 · wk-form4_1726604238.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,349 F1 · shares: On February 25, 2024, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,618 unvested restricted stock units which were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2025 Annual Meeting of Stockholders. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:07 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 65.537 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000177 · wk-form4_1725566857.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,107.171 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 23:16 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 1,000 | $113.55 | $113,550.00 |
DisclosureSEC source: 0001093557-24-000131 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,349 F1 · shares: On February 25, 2024, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,618 unvested restricted stock units which were granted on May 22, 2024 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2025 Annual Meeting. Read SEC document |
| May 28, 2024 Filed May 30, 2024 20:54 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 74.541 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000124 · wk-form4_1717102486.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,041.634 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 22, 2024 Filed May 24, 2024 21:40 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-24-000117 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,349 F1 · shares: The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. Read SEC document |
| May 07, 2024 Filed May 9, 2024 16:14 UTC | INTEGRAL AD SCIENCE HOLDING CORP. IAS · Entity 70858 | GrantCommon Stock, $0.001 par value | 13,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001842718-24-000052 · wk-form4_1715285681.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,024 F1 · kind: Represents Restricted Stock Units which will be settled in shares of common stock of the Issuer and will vest in full on the anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:05 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 77.198 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000067 · wk-form4_1709327132.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,967.093 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 30, 2024 Filed Feb 1, 2024 21:26 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 5,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-24-000033 · wk-form4_1706822767.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,889.895 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 08, 2023 Filed Dec 12, 2023 22:46 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 65.895 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000288 · wk-form4_1702421176.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,904.895 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. F2 · balance_after: Includes an adjustment to the number of deferred stock units held by the Reporting Person in connection with the completion of the separation of the Issuer's uniforms and workplace supplies business on September 30, 2023. Read SEC document |
| September 12, 2023 Filed Sep 13, 2023 23:55 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 600 | $106.56 | $63,936.00 |
DisclosureSEC source: 0001093557-23-000201 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,731 F1 · shares: On June 13, 2023, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,911 unvested restricted stock units which were granted on May 18, 2023 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Read SEC document |
| August 29, 2023 Filed Aug 31, 2023 00:50 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 39.611 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000177 · wk-form4_1693442994.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,583.001 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:42 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 37.63 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000136 · wf-form4_168573855764241.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,543.39 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 18, 2023 Filed May 22, 2023 19:48 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 2,911 | $0.00 | $2.91 |
DisclosureSEC source: 0001093557-23-000138 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,331 F1 · shares: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 2,911 unvested restricted stock units which were granted on May 18, 2023 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Read SEC document |
| May 11, 2023 Filed May 15, 2023 16:48 UTC | INTEGRAL AD SCIENCE HOLDING CORP. IAS · Entity 70858 | GrantCommon Stock, $0.001 par value | 9,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001842718-23-000053 · wk-form4_1684183677.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,393 F1 · kind: Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on the anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:12 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 39.387 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000087 · wf-form4_167848272708512.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,505.76 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:10 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-23-000052 · wf-form4_167580782542729.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,466.373 F1 · shares: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 23:23 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 24.704 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-22-000273 · wf-form4_167045541622470.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,313.373 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 20:36 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 28.621 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-22-000176 · wf-form4_166206456969129.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,288.669 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:20 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 29.828 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-22-000133 · wf-form4_165428763222094.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,260.048 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 24, 2022 Filed May 25, 2022 16:15 UTC | INTEGRAL AD SCIENCE HOLDING CORP. IAS · Entity 70858 | GrantCommon Stock, $0.001 par value | 12,521 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-019463 · doc4.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,512 Read SEC document |
| May 20, 2022 Filed May 23, 2022 21:05 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 988 | $0.00 | $0.99 |
DisclosureSEC source: 0001093557-22-000118 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,355 F1 · shares: The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 2,000 unvested restricted stock units, 988 of which were granted on May 20, 2022 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2023 Annual Meeting and 1,012 of which were granted on September 13, 2019 and shall vest through September 13, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 22:31 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 27.635 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-22-000083 · wf-form4_164643305716744.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,230.22 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:28 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-22-000042 · wf-form4_164392369036682.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,202.585 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 22:38 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 14.221 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000291 · wf-form4_163908947962621.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,572.585 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 22:15 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 14.743 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000206 · wf-form4_163122572569034.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,558.364 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 21:58 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 13.389 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000138 · wf-form4_162344868623498.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,543.621 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| May 21, 2021 Filed May 25, 2021 23:55 UTC | DEXCOM INC DXCM · Entity 3114 | GrantCommon Stock | 919 | $0.00 | $0.92 |
DisclosureSEC source: 0001093557-21-000144 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,367 F1 · shares: The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 2,943 unvested restricted stock units, 919 of which were granted on May 21, 2021 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2022 Annual Meeting and 2,024 of which were granted on September 13, 2019 and shall vest through September 13, 2022. Read SEC document |
| March 03, 2021 Filed Mar 6, 2021 00:32 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 12.232 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000080 · wf-form4_161499074491160.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,530.232 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 23:07 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-21-000036 · wf-form4_161248005083004.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 22:12 UTC | DEXCOM INC DXCM · Entity 3114 | SaleCommon Stock | 375 | $356.65 | $133,743.75 |
DisclosureSEC source: 0001093557-20-000325 · edgardoc.xml · nonDerivative · entry 1 Heller Bridgette P · CIK 0001485616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 F1 · shares: On September 15, 2020, Ms. Heller adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Heller. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 2,811 unvested restricted stock units, 787 of which were granted on May 22, 2020 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2021 Annual Meeting and 2,024 of which were granted on September 13, 2019 and shall vest through September 13, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.